New HIV drug shows promise in early trial
NCT ID NCT05869643
First seen Feb 06, 2026 · Last updated May 19, 2026 · Updated 16 times
Summary
This study tested a new experimental drug, STP0404, in 25 adults with HIV who had never taken HIV medications before. The goal was to see how well the drug lowers the amount of virus in the blood and to check for side effects over a 10-day period. The results will help decide if larger studies should be done.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Atrium Health Wake Forest Baptist Medical Center - PPDS
Winston-Salem, North Carolina, 27157, United States
-
Be Well Medical Center
Berkley, Michigan, 48072, United States
-
Kaiser Permenente Los Angeles Medical Center
Los Angeles, California, 90027, United States
-
Midway Immunology and Research Center
Ft. Pierce, Florida, 34982, United States
-
North Shore University Hospital
Manhasset, New York, 11030-3816, United States
-
North Texas Infectious Diseases Consultants, P.A.
Dallas, Texas, 75246, United States
-
Orlando Immunology Center
Orlando, Florida, 32803, United States
-
Ruane Clinical Research, Inc.
Los Angeles, California, 90036, United States
-
Saint Michael's Medical Center
Newark, New Jersey, 07102, United States
-
Schiff Center for Liver Diseases/University of Miami
Miami, Florida, 33136-2107, United States
-
South Jersey Infectious Disease
Somers Point, New Jersey, 08244, United States
-
St Hope Foundation, Inc
Bellaire, Texas, 77401, United States
-
USF Health South Tampa Center for Advanced Healthcare
Tampa, Florida, 33602-3511, United States
Conditions
Explore the condition pages connected to this study.